Results 201 to 210 of about 5,325,323 (353)

Regional height growth models for Scots pine in Poland. [PDF]

Sci Rep, 2021
Socha J, Tymińska-Czabańska L, Bronisz K, Zięba S, Hawryło P.   +4 more
europepmc   +1 more source

Therapeutic strategies for MMAE‐resistant bladder cancer through DPP4 inhibition

Molecular Oncology, EarlyView.
We established monomethyl auristatin E (MMAE)‐resistant bladder cancer (BC) cell lines by exposure to progressively increasing concentrations of MMAE in vitro. RNA sequencing showed DPP4 expression was increased in MMAE‐resistant BC cells. Both si‐DPP4 and the DPP4 inhibitor sitagliptin suppressed the viability of MMAE‐resistant BC cells.
Gang Li, Shuichi Tatarano, Hirofumi Yoshino, Saeki Saito, Mitsuhiko Tominaga, Junya Arima, Ikumi Fukuda, Takashi Sakaguchi, Ryosuke Matsushita, Yasutoshi Yamada, Hideki Enokida   +10 more
wiley   +1 more source

A descriptive model for peach fruit growth.

, 2000
A. Galassi, G. Miotto, P. Cappellini
openalex   +2 more sources

Consistently Tuned Battery Lifetime Predictive Model of Capacity Loss, Resistance Increase, and Irreversible Thickness Growth

, 2023
Sravan Pannala, Hamidreza Movahedi, Taylor R. Garrick, Jason B. Siegel, Anna G. Stefanopoulou   +4 more
openalex   +2 more sources

Bayesian inference in nonlinear growth models and hypothesis testing of sexual dimorphism in Black Utrerana chickens. [PDF]

Poult Sci
Salvador RC, Pereira AA, Fernandes TJ.
europepmc   +1 more source

Importance of the description of light interception in crop growth models. [PDF]

Plant Physiol, 2021
Liu S, Baret F, Abichou M, Manceau L, Andrieu B, Weiss M, Martre P.   +6 more
europepmc   +1 more source

Recurrent cancer‐associated ERBB4 mutations are transforming and confer resistance to targeted therapies

Molecular Oncology, EarlyView.
We show that the majority of the 18 analyzed recurrent cancer‐associated ERBB4 mutations are transforming. The most potent mutations are activating, co‐operate with other ERBB receptors, and are sensitive to pan‐ERBB inhibitors. Activating ERBB4 mutations also promote therapy resistance in EGFR‐mutant lung cancer.
Veera K. Ojala, Sini Ahonen, Sara Peltola, Aura Tuohisto‐Kokko, Olaya Esparta, Peppi Suominen, Anne Jokilammi, Iman Farahani, Deepankar Chakroborty, Nikol Dibus, Steffen Boettcher, Tomi T. Airenne, Mark S. Johnson, Lisa D. Eli, Klaus Elenius, Kari J. Kurppa   +15 more
wiley   +1 more source

Verification of rail roughness growth model for rail corrugation due to periodic measurement

, 2017
Hirofumi Tanaka, Masashi Miwa
openalex   +1 more source

Recovering knot placements in Bayesian piecewise growth models with missing data. [PDF]

Behav Res Methods
Heo I, Jia F, Depaoli S.
europepmc   +1 more source

Peroxidasin enables melanoma immune escape by inhibiting natural killer cell cytotoxicity

Molecular Oncology, EarlyView.
Peroxidasin (PXDN) is secreted by melanoma cells and binds the NK cell receptor NKG2D, thereby suppressing NK cell activation and cytotoxicity. PXDN depletion restores NKG2D signaling and enables effective NK cell–mediated melanoma killing. These findings identify PXDN as a previously unrecognized immune evasion factor and a potential target to improve
Hsu‐Min Sung, David Bickel, Lena C. M. Krause, Daria Ezeriņa, Christian Ickes, Julian Wojtachnia, Christine S. Gibhardt, Magdalena Shumanska, Khadija Wahni, Andrea Paluschkiwitz, Julia Malo Pueyo, Ekaterina Baranova, Wim Vranken, Hedwig Stanisz, Ioana Stejerean‐Todoran, Michael P. Schön, Joris Messens, Ivan Bogeski   +17 more
wiley   +1 more source